Discover our latest insights. 

Obesity is a well-established risk factor for numerous chronic conditions, including type 2 diabetes, cardiovascular disease, liver disease, certain cancers, and obstructive sleep apnea. Evidence suggests that effective obesity treatment could potentially …

This winter, navigating respiratory illnesses just got easier with the FDA’s authorization of the first at-home combination tests for SARS-CoV-2 and the flu. Healgen® Scientific’s Rapid Check COVID-19/Flu A&B Antigen Test simplifies …

The U.S. Food and Drug Administration approved neffy®, the first-ever nasal spray form of epinephrine, offering a needle-free alternative for treating severe, life-threatening allergic reactions, or anaphylaxis. This innovation may encourage timely …

Nearly half of women over 40 have dense breast tissue, which can make it more difficult to detect cancer by mammography and can increase breast cancer risk. As of September 2024, the …

There are over 7,000 rare diseases that affect very small numbers of patients around the world. Due to the rarity of these conditions, it can be difficult to conduct the research needed to better understand them and to develop effective treatments. One rare disease that has recently come into the spotlight is called Stiff Person Syndrome (SPS). In 2022, global superstar Celine Dion revealed that she had been diagnosed with SPS, which had caused her to stop performing. This year, she released a documentary shedding light on her struggles with SPS symptoms and raising awareness.

Clinical trials are pivotal in cancer treatment innovation, offering new hope and possibilities for patients. At Private Health Management (PHM), we understand that the decision to participate in a clinical trial can be daunting. Our team of experienced research scientists, clinicians, and care coordinators provide expert, independent advice tailored to each patient’s individual needs and care goals. By demystifying the process and highlighting the potential benefits, we strive to make clinical trials a viable and accessible option for patients who can benefit the most.